美国 · 股市与财经 · Barron's
Foghorn Stock Craters as Lilly Scraps Cancer Deal, Forcing 40% Layoffs
Foghorn Therapeutics and Eli Lilly don’t plan any future collaborations following the dissolution of a cancer-drug partnership.
在 Barron's 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要,全文请在出版方网站阅读。 (www.barrons.com)




